Posted by Defense World Staff on Nov 16th, 2024
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Equities research analysts at Wedbush issued their FY2024 earnings per share estimates for Prime Medicine in a research report issued to clients and investors on Tuesday,...
More of this article »